Fatty Liver & Elevated Cholesterol
Disclaimer
The Fullscript Integrative Medical Advisory team has developed or collected these protocols from practitioners and supplier partners to help health care practitioners make decisions when building treatment plans. By adding this protocol to your Fullscript template library, you understand and accept that the recommendations in the protocol are for initial guidance and may not be appropriate for every patient.
Fatty Liver & Elevated Cholesterol
Total Protocol Duration: 12 weeks
Liver Support
1 capsule, 3 times daily on an empty stomach, week 1 to 12.
Description: Comprehensive liver formula containing NAC and sulforaphane precursors.
Solufibre
1 scoop, 2 times daily after or between, week 1-12.
Description: Patented and studied hydrolyzes guar gum, no taste or thick texture, fully dissolves into water. Lowers cholesterol.
Optional: Pro Phase II Detox
2 capsules, 2 times daily with food, week 1-12. Take 2-3 hours away from medication.
Description: Hepatosis and endotoxemia may influence the development of NAFLD.
Optional: High Dose R + Lipoic Acid or Pro Lipoic Acid
1 capsule, 2 times daily with or without food, week 1- 12.
Description: For those with insulin resistance and suspected glucotoxicity, lipoic acid supports health blood sugar metabolism.
The following may be considered according to requirements for additional support:
High simple carbohydrate intake, including fructose, contributes to glucotoxicity and the pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD). Consider low glycemic diet and elimination of processed foods.
AOR Professional not available in retail health-food stores or online to the general public
Fullscript content philosophy
At Fullscript, we are committed to curating accurate, and reliable educational content for practitioners and patients alike. Our educational offerings cover a broad range of topics related to integrative medicine, such as supplement ingredients, diet, lifestyle, and health conditions.
Medically reviewed by expert practitioners and our internal Integrative Medical Advisory team, all Fullscript content adheres to the following guidelines:
- In order to provide unbiased and transparent education, information is based on a research review and obtained from trustworthy sources, such as peer-reviewed articles and government websites. All medical statements are linked to the original reference and all sources of information are disclosed within the article.
- Information about supplements is always based on ingredients. No specific products are mentioned or promoted within educational content.
- A strict policy against plagiarism is maintained; all our content is unique, curated by our team of writers and editors at Fullscript. Attribution to individual writers and editors is clearly stated in each article.
- Resources for patients are intended to be educational and do not replace the relationship between health practitioners and patients. In all content, we clearly recommend that readers refer back to their healthcare practitioners for all health-related questions.
- All content is updated on a regular basis to account for new research and industry trends, and the last update date is listed at the top of every article.
- Potential conflicts of interest are clearly disclosed.